Closed
SectorHealthcare
62.41 -5.71
24h
Min
60.73
Max
65.81
Income | 35M 50M |
|---|---|
Sales | 32M 108M |
Profit margin | 45.833 |
Employees | 104 |
EBITDA | 29M 68M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +25.84% upside |
Next Earnings | 1 maj 2026 |
|---|
Market Cap | 378M 1.9B |
|---|---|
Previous open | 68.12 |
Previous close | 62.41 |
By Acuity
62%
38%
321 / 348 Ranking in Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 78.45 USD 25.84%
High 140 USD
Low 50 USD
Based on 11 Wall Street analysts offering 12 month price targets forAnaptysBio Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$